Abstract
Introduction
Breast cancer prevalence is growing worldwide. Many factors, such as diet and lifestyle could be determinants of the incidence of breast cancer. Coffee has been extensively studied in relation to several chronic diseases because of its multiple effects in health maintenance and its elevated consumption. We studied the relationship between coffee intake and breast cancer risk in the SUN (Seguimiento Universidad de Navarra) prospective cohort.
Materials and methods
We evaluated 10,812 middle-aged, Spanish female university graduates from the SUN Project, initially free of breast cancer. Coffee consumption was assessed with a 136-item validated food-frequency questionnaire (FFQ). Incident breast cancer cases were confirmed by a trained oncologist using medical records and by consultation of the National Death Index. We fitted Cox regression models to assess the relationship between baseline categories of coffee consumption and the incidence of breast cancer during follow-up. We stratified the analysis by menopausal status.
Results
During 115,802 person-years of follow-up, 101 new cases of breast cancer were confirmed. Among postmenopausal women, more than 1 cup of coffee per day was associated with a lower incidence of breast cancer (HR 0.44; 95% confidence interval: 0.21, 0.92) in the fully adjusted model, compared to women who consumed one cup of coffee or less per day. We observed no significant differences in regard to premenopausal women.
Conclusion
Even though the number of cases was low, slight indications of an inverse association between coffee consumption and breast cancer risk among postmenopausal women were observed. Further longitudinal studies are warranted to confirm this finding.
Similar content being viewed by others
Introduction
Breast cancer (BC) is the first cause of cancer death among women. Indeed, the prevalence of BC is the leading cause among all types of cancers [1]. Although genetic or environmental factors can be responsible for BC development, available evidence suggests that diet may be one of the most important determinants of BC occurrence [2]. In fact, several studies have highlighted the importance of lifestyles in the development of BC, which are also directly related to pathophysiological mechanisms present in obesity, metabolic syndrome and/or cardiovascular disease [3, 4].
Hitherto, coffee consumption has been suggested to decrease risk of Parkinson’s disease, type 2 diabetes, cardiovascular diseases and breast, colorectal, endometrial, prostate cancers and even all-cause mortality [5,6,7,8]. Coffee consumption has also been linked to a lower risk of premenopausal BC [9,10,11] and postmenopausal BC in different cohort studies, among them, 21 cohort studies were included in a recent meta-analysis [9, 12,13,14]. However, none of them adjusted for an overall dietary pattern although coffee consumption may be associated with a holistic dietary pattern [10].
Some effects of coffee consumption on chronic disease have been traditionally attributed to caffeine, an alkaloid widely present in coffee [15]. However, the association between caffeine intake and BC risk in observational studies is still inconsistent; while one study found no significant association [16], others did [9, 12]. On the other hand, coffee also contains other minor components such as diterpenes, polyphenols like chlorogenic acids, melanoidins, N-methylpyridinium and acrylamide, whose concentrations depend on the handling and the variety of coffee studied [17, 18]. The potential biological actions of these minor components—which may interact in synergy—on the prevention of BC ranged from regulation of DNA repair, proapoptotic, antiproliferative, antiangiogenic and anti-metastatic effects to antioxidant properties as regulation of Nrf2 and Kelch-like ECH-associated protein 1 [5, 19]. In fact, coffee is the main source of polyphenol intake in several populations in which the aforementioned studies on the association between coffee consumption and BC were conducted [20]. However, no previous study on this association has been conducted in countries such as Spain in which the main source of polyphenol intake is fruits and vegetables [21, 22] and therefore, the association between coffee consumption and BC risk may be different.
We investigated whether coffee consumption is associated with BC overall and we stratified the results by menopausal status in a prospective cohort of Spanish university graduates, after adjusting for the overall dietary pattern.
Materials and methods
Study sample
The “Seguimiento Universidad de Navarra” (SUN) project is a prospective, multipurpose cohort of Spanish university graduates. The study methods have been described in more detail elsewhere [23]. Briefly, the SUN project is a dynamic cohort where the recruitment is permanently open assessing the relationship between diet and chronic diseases. It was developed inspired by the models of the Nurses’ Health Study and the Health Professionals Follow-Up Study. Recruitment started in December 1999.
After the initial questionnaire, follow-up questionnaires are mailed every 2 years to participants to update information on diet and lifestyle and collect information on health outcomes which might have happened in the previous 2 years. For participants lost to follow-up, the National Death Index is consulted periodically to assess their vital status and cause of death. Participants are middle-aged university graduates from different Spanish regions.
By 2018, 22,791 participants were recruited. To allow the minimal follow-up of 2 years, we included only those participants who were recruited before October 2015 (2.75 years before the database closing date). Out of 13,770 eligible women, we excluded 1295 participants with no follow-up information (retention 90.6%); 104 participants with self-reported previous history of BC at baseline, 1353 participants with total energy intake out of predefined limits (< 500 or > 3500 kcal/day) [24], or reported menopause before the age of 35 years (n = 206). The final sample consisted of 10,812 participants who answered at least one follow-up questionnaire.
This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving participants were approved by the Institutional Review Board of the University of Navarra. Voluntarily given informed consent through freely fulfillment of the baseline questionnaire were gathered from all participants according to the methods approved by our Institutional Review Board.
Assessment of coffee consumption
The baseline questionnaire included a previously validated 136-item food-frequency questionnaire (FFQ) [25, 26]. The reproducibility of the FFQ has been specifically addressed in this cohort [27]. The serving size for coffee was 50 cc or a cup size. Information about the consumption of regular and decaffeinated coffee was gathered separately. The FFQ assessed habitual food consumption over the previous 12 months and included nine categories of response for the frequency of consumption, ranging from ‘never/seldom’ to ‘more than six times per day’. Then, participants were grouped in two categories according to their level of coffee consumption (≤ 1 cup/day and > 1 cup/day). Consumption of regular and decaffeinated coffee was added to quantify total coffee consumption.
Ascertainment of incident breast cancer cases
For the present analysis, incident BC was the primary endpoint. Participants were asked whether they had received a medical diagnosis of BC at baseline and during follow-up. Incident BC was defined as women who developed BC during the follow-up and were free of the disease at the beginning of the study. They were also inquired about the date of diagnosis. Self-reported BC cases were considered as probable cases. These participants were asked for a copy of their medical records. Then, a trained oncologist confirmed the cases. Moreover, deaths were reported to the research team by subject’s next of kin, work associates and postal authorities. If lost during the follow-up or with unidentified causes of death, the National Death Index was consulted periodically to identify deceased cohort members and confirm the cause of death. Both cases adjudicated by a trained oncologist and deaths due to BC were considered as confirmed BC cases (n = 101) (false positives, n = 7). These trained oncologists were blinded with respect to dietary exposures.
Assessment of covariates
Mediterranean diet adherence was assessed using the score proposed by Trichopoulou et al. with some modifications [28], which consisted of using an 8-point Mediterranean-diet scale ranging from 0 to 8 (because we removed the moderate alcohol component due to the postulated detrimental effect of alcohol on BC). Participants received one point if they were above the median for the consumption of each of six typical elements of this dietary pattern (vegetables, legumes, fruits and nuts, cereal, fish and the monounsaturated/saturated ratio intake), and another point was added if they were below the median for the consumption of two items that were not included in the traditional Mediterranean diet (red meat and meat products and dairy products). Coffee consumption was not considered as part of this score.
The baseline questionnaire also included information about participants’ socio-demographic characteristics, medical history (prevalent chronic diseases), health-related habits, lifestyles, anthropometric data, physical activity and family history of BC [29, 30]. We included as ultraprocessed foods the total amount of the food items meeting the ultraprocessed food category of the NOVA system [31] petit suisse, breakfast cereals, milkshakes, custard, pudding, ice-cream, potato chips, cookies, muffins, donuts, croissant, cakes, churros, chocolates, nougat, marzipan, ready-to-consume pies, pizza, instant soups and creams, margarine, mayonnaise, sugar sweetened beverages, diet soft drinks, bottled fruit juice, processed meat (cooked ham, spicy pork sausage, salami, mortadella, foie-gras, black pudding, bacon, hamburger, sausage), and alcoholic drinks produced by fermentation followed by distillation such as whisky, gin, rum or vodka.
Statistical analysis
Baseline quantitative traits of participants were described as the means and standard deviations according to categories of coffee consumption and baseline qualitative traits as the percentages across the same categories.
We assessed the correlation between coffee consumption and other beverage consumption with Pearson’s correlation coefficients.
To assess the relation between baseline total coffee consumption (categorized as ≤ 1 cup/day and > 1 cup/day) and the subsequent risk of BC, we used Cox regression models with age as underlying time variable, stratified the Cox regression models for age (decades) and recruitment period (three periods) and included confirmed incident cases as the outcome. Baseline regular coffee was separately assessed. Regular coffee consumption was categorized as ≤ 1 cup/day and > 1 cup/day. Additionally, baseline regular and total coffee consumption were separately assessed as continuous variables, to describe the association according to the change in one cup of regular or total coffee consumption. We defined follow-up for each participant from the date of completion of the baseline questionnaire to the date of BC diagnosis for cases and to the last returned questionnaire for non-cases. Probable incident cases were considered as non-cases and censored at the date of self-reported diagnosis. Hazard ratios (HR) and their 95% CI were calculated considering the lowest category of coffee consumption as the reference category.
For all analyses, we fitted several multivariable models with successive degrees of adjustment for potential confounders. Model 1 was adjusted for height (continuous), family history of BC (yes/no), smoking status (never smoker, former smoker, current smoker), smoking package-years (continuous), physical activity (MET-h/week, continuous), alcohol intake (g/day, continuous), BMI (continuous), age of menarche (< 10 years, 10–11 years, 12–13 years, 14–16 years, > 16 years), menopause (no menopause, < 50 years, ≥ 50 years), number of pregnancies of more than 6 months (continuous), pregnancy before the age of 30 years (yes/no), months of breastfeeding (continuous), use of hormone replacement therapy (yes/no) and its duration (continuous) and years at university (continuous).
Model 2 included additional adjustment for prevalent diabetes (yes/no), BMI (quadratic), total energy intake (kcal/day, continuous; linear and quadratic terms), ultra-processed food consumption (servings/day), sugar-sweetened beverages consumption (yes/no) and adherence to the Mediterranean diet (continuous).
Dietary data were updated after 10 years of follow-up to lessen the potential effect of diet variation during follow-up, and time-varying Cox proportional hazard models were fitted with repeated measures of the coffee intake.
Subsequently, we ran stratified analysis among pre- or postmenopausal women and their risk of BC. Information on age at menopause was collected in the baseline questionnaire and after 16 years of follow-up. If information regarding the age at menopause was lacking, we imputed postmenopausal status according to the 75th percentile of age at menopause in the study population (52 years of age) (n = 3132) [32]. When assessing premenopausal BC as the outcome, we excluded those women who reported having had menopause before study inception and censored follow-up time at the age of 52 years or at the self-reported age of menopause, whichever happened first. For postmenopausal BC, we considered women at risk only those after having turned 52-year-old or after the self-reported age of menopause, whichever happened last. In the analysis with postmenopausal BC as outcome, we additionally adjusted for age at menopause (< 50 years, ≥ 50 years) and time since recruitment until the beginning of the time at risk. The latter was 0 for women who were already postmenopausal at study inception. For women who were initially premenopausal but turned postmenopausal during follow-up, time since recruitment was calculated as the difference between the initial date of being at risk of postmenopausal BC and the date of completion of the baseline questionnaire.
To assess effect modification, differences in the association of the exposure with breast cancer by menopausal status were evaluated with interaction and with the likelihood ratio test. The p value for interaction by menopausal status was calculated by comparing models with or without a multiplicative interaction term between menopausal status and coffee consumption.
Finally, based on the question “Do you add sugar to some beverages?”, we separated coffee consumption of those participants who added sugar from those who did not and assessed the interaction between adding sugar to coffee or not in their relationship to BC with the likelihood ratio test.
As sensitivity analyses, we repeated our analyses with probable BC cases and explored the robustness of our results using other cut-offs criteria for energy intake, and using total coffee intake as the main exposure (Fig. 1). Particularly, we used the basal metabolic rate (BMR) and excluded people under BMR*1.2 and/or over BMR*1.9 using the Miffil-St Jeor equation [33] or under or above the percentiles 5 and 95, respectively, of the ratio between total energy intake and BMR. We also performed further analyses using different exposure cut-off points (< 1 cup/day, 1 cup/day, > 1 cup/day).
Analyses were carried out using Stata version 12.0 (Stata Corporation). All p values were two-tailed and a p value < 0.05 was deemed as statistically significant.
Results
The main baseline characteristics of the 10,812 women included in our analyses according to categories of baseline total coffee consumption are shown in Table 1. The median age of participants was 32 years and the mean BMI was 22.2 kg/m2 (SD 3.1). Participants in the highest category of total coffee consumption were older and less physically active, had a higher BMI, higher total energy intake and intake of alcohol, meat, fruits, vegetables, olive oil and dairy products, higher adherence to the Mediterranean diet and lower cereal consumption compared to women with 1 or less cup/day of coffee consumption.
Coffee consumption did not show strong inverse correlation coefficients with any other beverage (Supplementary Table 1).
Incidence of breast cancer
We identified 189 probable incident cases of BC. Out of these, we confirmed 101 new-onset cases of BC among 115,802 person-years of follow-up (median follow-up 11.8 years).
We observed no significant association between total coffee consumption and overall BC risk when we considered either confirmed cases (adjusted HR 1.11; 95% CI 0.74, 1.66) (Table 2) or probable cases (adjusted HR 1.10; 95% CI 0.82, 1.48) (Supplementary Table 2). Results did not change substantially when we set other cut-off points for total energy intake (Fig. 1). Adding sugar to beverages did not modify the described association.
We did not observe any association with overall BC risk when we considered regular coffee consumption (adjusted HR 1.20; 95% CI 0.80, 1.79) (Supplementary Table 3), or when we addressed this association including also probable cases (Supplementary Table 2).
Incidence of premenopausal and postmenopausal breast cancer
When we divided participants according to menopausal status and considered coffee consumption of less or equal than 1 cup/day as the reference category, consumption of more than 1 cup/day of coffee among premenopausal women was associated with a non-significant increased risk of BC (adjusted HR 1.69; 95% CI 0.96, 2.96) (Table 3). The associations remained non-significant when we considered only regular coffee consumption (Supplementary Table 4) or when we included also probable cases of premenopausal BC (Supplementary Table 5). Results barely changed in sensitivity analyses concerning energy intake limits (Fig. 1) or other exposure cut-off points as shown in Supplementary Table 6.
On the other hand, postmenopausal women who consumed more than 1 cup/day of coffee showed a significantly lower risk of BC (adjusted HR 0.44; 95% CI 0.21, 0.92) in the fully adjusted model compared to postmenopausal women in the lowest consumption category (Table 3). Results were consistent when we considered only confirmed cases or all probable cases (Supplementary Table 5) as well as when we set other exclusion criteria (Fig. 1) or other exposure cut-off points in the sensitivity analyses (Supplementary Table 6).
No significant association was found between regular coffee consumption (adjusted HR 1.35; 95% CI 0.92, 1.97) and postmenopausal BC risk when we considered all cases, including also probable cases (Supplementary Table 5). When we restricted the analysis to confirmed cases, we could only estimate the association between regular coffee consumption and postmenopausal BC risk which was not statistically significant (Supplementary Table 4).
When the analyses were updated with repeated measures, the results remained similar and were statistically significant for postmenopausal women (adjusted HR 0.43; 95% CI 0.21, 0.90).
The interaction between coffee consumption and menopausal status in their association with BC was statistically significant (p value = 0.008). There was a statistically significant inverse association between coffee consumption and BC among postmenopausal women (HR:0.44; 95% CI 0.21, 0.92) whereas the association was not statistically significant for premenopausal women (HR: 1.69; 95% CI 0.96, 2.96).
Discussion
In this prospective study of Mediterranean university graduates, we observed no association between coffee consumption and overall breast cancer risk. In ancillary analyses, according to menopausal status, we found a lower risk of BC among postmenopausal women who consumed more than one cup of coffee per day compared to those who consumed one cup or less per day, even after adjustment for the overall dietary pattern. Moreover, a statistically significant interaction between menopausal status and BC incidence associated to coffee consumption was found. However, no significant association between coffee consumption and BC was observed among premenopausal women. What is more, the point estimate for the association among premenopausal women was towards the opposite direction and our results were compatible with a potential detrimental association among premenopausal women.
This inverse association between coffee consumption (> 1 cup/day versus lower consumption) and postmenopausal BC incidence is consistent with previous literature. Lafranconi et al. pooled a total of 21 prospective studies and observed that women who consumed at least two cups of coffee per day showed a lower risk of BC compared to non-consumers and the association was stronger for postmenopausal women [12]. Li et al. conducted another meta-analysis in which they also distinguished between estrogen receptor-positive (ER+) and estrogen receptor-negative (ER−) BC. They included 23 studies and found a borderline significant influence of highest coffee consumption, which corresponds to 2 cups/day increment in coffee intake, (RR 0.98; 95% CI 0.97–1.00) on the risk of overall BC but an inverse association between coffee consumption and ER-BC [34].
Regarding the different types of coffee, regular coffee consumption was not significantly associated with overall, premenopausal or postmenopausal BC risk. Indeed, no significant association between either caffeinated or decaffeinated coffee and BC risk was observed in the NIH-AARP Diet and Health Study cohort [35]. However, regular coffee intake was associated with lower risk of postmenopausal BC (HR 0.90, 95% CI 0.82–0.98) in the EPIC study [36]. Nevertheless, according to current data, there is no sufficient evidence to support the idea that regular coffee consumption is more strongly associated with BC occurrence than decaffeinated coffee. Thus, it seems that beneficial properties of coffee against BC risk cannot be attributed only to caffeine.
Coffee is composed by several and distinct constituents besides caffeine: diterpenes (coffee lipids), phenolic acids (polyphenols), melanoidins, N-methylpyridinium and acrylamide. Concentrations of these single components may vary due to coffee variety, handling, effect of time, roasting temperature and preparation method [37,38,39,40] and, consequently, the effects of coffee consumption may also be different according to the type of coffee. The type of coffee might be important due to the quantity of polyphenols and diterpenes that could vary depending on it [37, 41, 42]. But, even in minor quantity, these compounds are found in all types of coffee. So, chlorogenic acids may regulate oxidative and inflammatory stress conditions [43], although these effects have been described to decrease with increasing roasting [38]. Regarding the potential health effects of these minor components, several of these coffee components, such as chlorogenic acid, trigonelline, kahweol, and cafestol, have been found to exert antioxidant and anti-inflammatory properties [44,45,46] which may prevent tumor appearance. Even more, some of these compounds (including polyphenols) have been described to possess antitumor and antimetastatic effects by inducing cell cycle arrest or promoting apoptosis of cancer cells (i.e., via PI3K-Akt) [34, 47, 48].
Our study has various potential limitations. First of all, our statistical power could be suboptimal, because of the reduced number of incident cases of BC. Our cohort is largely constituted by young women, which diminishes the number of incident BC cases. In fact, we were not able to estimate the association between decaffeinated coffee consumption and the risk of postmenopausal BC due to the low number of cases, nor were we able to address the association between a greater number of categories of coffee consumption and BC. Second, self-reported information used on coffee consumption may imply some degree of misclassification which in turn, may bias our results towards the null. However, dietary information was collected with a previously validated semi-quantitative food-frequency questionnaire [26, 27]. Third, coffee consumption was assessed only at baseline in the main analyses, but this may not represent a strong limitation given that coffee consumption tends to remain stable over the years and we also repeated our analyses with updated information on coffee consumption after 10 years of follow-up [49, 50]. Fourth, the lack of information regarding the method of preparation, type and variety of coffee could be a strong limitation; however, previous studies reported that non-filtered coffee is the main type of coffee consumed in Spain. This latter variety includes coffee prepared with the use of pressure (espresso coffee), a percolator (a type of pot that brews coffee by passing boiling water over the grounds), and instant coffee [49]. Fifth, information on BC incidence was self-reported. We acknowledge that we might have missed some BC cases. However, to avoid false positives, BC cases were confirmed by a trained oncologist. Sixth, we did not have a representative sample of the general population. However, from the point of view of biological plausibility, the association between coffee consumption and BC risk does not have to be different for highly educated women than for women with a lower educational level. Moreover, most cohorts and other analytical studies are usually non-representative, and this represents no problem given that the generalization should be based on biological plausibility. Seventh, postmenopausal status was imputed and derived by censoring which might result in classification errors. Eighth, since tea was not widely consumed in Spain by the time the FFQ was developed, tea was not selected as a relevant item to be included in the FFQ and we had no information on tea consumption. Ninth, we aimed to assess if adding sugar to coffee significantly modified the results. Nevertheless, this question was not limited to coffee consumption but included all beverages and we did not have information on artificial sweeteners. In fact, we could not distinguish if sugar—or similarly milk—were poured into coffee or into other beverages since dietary information was collected with an FFQ.
Nonetheless, our study also has some strengths, starting from its longitudinal design that reduces the possibility of reverse causation bias and the adjustment for many potential confounders which have been included in the multivariable analyses, although we cannot completely rule out the possibility of residual confounding. Biological plausibility is described with anti-inflammatory and antioxidant effects of coffee compounds, and, furthermore, coffee has been described to exert antitumoral effects in several types of cancers besides BC.
In conclusion, according to our results there are slight indications of an inverse association between coffee consumption and postmenopausal BC risk. These findings are consistent with previous studies and support the idea that coffee could be incorporated in a healthy diet.
Abbreviations
- BC:
-
Breast cancer
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- EPIC:
-
European prospective investigation into cancer and nutrition
- HR:
-
Hazard ratio
- MET:
-
Metabolic equivalent
- NHS:
-
Nurses’ Health Study
- PREDIMED:
-
PREvención con DIeta MEDiterránea
- SD:
-
Standard deviation
- SUN:
-
Seguimiento Universidad de Navarra, Follow-up University of Navarra
- WCRF:
-
World Cancer Research Fund
References
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
World Cancer Research Fund, American Institute for Cancer Research (2017) Diet, nutrition, physical activity and breast cancer. https://www.wcrf.org/sites/default/files/Breast-Cancer-2017-Report.pdf. Accessed 31 Oct 2019
Weigl J, Hauner H, Hauner D (2018) Can nutrition lower the risk of recurrence in breast cancer. Breast Care 13:86–91. https://doi.org/10.1159/000488718
Pharr JR, Coughenour CA, Bungum TJ (2018) An assessment of the relationship of physical activity, obesity, and chronic diseases/conditions between active/obese and sedentary/ normal weight American women in a national sample. Public Health 156:117–123. https://doi.org/10.1016/j.puhe.2017.12.013
Grosso G, Godos J, Galvano F, Giovannucci EL (2017) Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr 37:131–156. https://doi.org/10.1146/annurev-nutr-071816-064941
Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11:96. https://doi.org/10.1186/1471-2407-11-96
Navarro AM, Martinez-Gonzalez M, Gea A et al (2018) Coffee consumption and total mortality in a Mediterranean prospective cohort. Am J Clin Nutr 108:1113–1120. https://doi.org/10.1093/ajcn/nqy198
Grosso G, Micek A, Godos J et al (2016) Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol 31:1191–1205. https://doi.org/10.1007/s10654-016-0202-2
Oh JK, Sandin S, Ström P et al (2015) Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer 137:1979–1989. https://doi.org/10.1002/ijc.29569
Sánchez-Villegas A, Toledo E, Bes-Rastrollo M et al (2009) Association between dietary and beverage consumption patterns in the SUN (Seguimiento Universidad de Navarra) cohort study. Public Health Nutr 12:351–358. https://doi.org/10.1017/S1368980008002127
Baker JA, Beehler GP, Sawant AC et al (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136:166–171. https://doi.org/10.1093/jn/136.1.166
Lafranconi A, Micek A, De PP et al (2018) Coffee intake decreases risk of postmenopausal breast cancer: a dose-response meta-analysis on prospective cohort studies. Nutrients. https://doi.org/10.3390/nu10020112
Ganmaa D, Willett WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076. https://doi.org/10.1002/ijc.23336
Jiang W, Wu Y, Jiang X (2013) Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol 129:620–629
Kolahdouzan M, Hamadeh MJ (2017) The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther 23:272–290
Ishitani K, Lin J, Manson JAE et al (2008) Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168:2022–2031. https://doi.org/10.1001/archinte.168.18.2022
Cossignani L, Montesano D, Simonetti MS, Blasi F (2016) Authentication of coffea arabica according to triacylglycerol stereospecific composition. J Anal Methods Chem. https://doi.org/10.1155/2016/7482620
de Melo PGV, de Carvalho Neto DP, Magalhães Júnior AI et al (2019) Exploring the impacts of postharvest processing on the aroma formation of coffee beans—a review. Food Chem 2016:7482620
Bøhn SK, Blomhoff R, Paur I (2014) Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58:915–930
Ovaskainen M-L, Törrönen R, Koponen JM et al (2008) Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr 138:562–566. https://doi.org/10.1093/jn/138.3.562
Tresserra-Rimbau A, Medina-Remón A, Pérez-Jiménez J et al (2013) Dietary intake and major food sources of polyphenols in a Spanish population at high cardiovascular risk: the PREDIMED study. Nutr Metab Cardiovasc Dis 23:953–959. https://doi.org/10.1016/j.numecd.2012.10.008
Gardeazabal I, Romanos-Nanclares A, Martínez-González MA et al (2018) Total polyphenol intake and breast cancer risk in the SUN cohort. Br J Nutr 122:542–551. https://doi.org/10.1017/S0007114518003811
Seguí-Gómez M, de la Fuente C, Vázquez Z et al (2006) Cohort profile: the “Seguimiento Universidad de Navarra” (SUN) study. Int J Epidemiol 35:1417–1422. https://doi.org/10.1093/ije/dyl223
Willett W (2012) Nutritional epidemiology. Oxford University Press, Oxford
Martin-moreno JM, Boyle P, Gorgojo L et al (1993) Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 22:512–519. https://doi.org/10.1093/ije/22.3.512
Fernández-Ballart JD, Piñol JL, Zazpe I et al (2010) Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 103:1808–1816. https://doi.org/10.1017/S0007114509993837
De la Fuente-Arrillaga C, Vázquez Ruiz Z, Bes-Rastrollo M et al (2010) Reproducibility of an FFQ validated in Spain. Public Health Nutr 13:1364–1372. https://doi.org/10.1017/S1368980009993065
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348:2599–2608. https://doi.org/10.1056/NEJMoa025039
Martínez-González MA, López-Fontana C, Varo JJ et al (2005) Validation of the Spanish version of the physical activity questionnaire used in the Nurses’ Health Study and the Health Professionals’ Follow-up Study. Public Health Nutr 8:920–927. https://doi.org/10.1079/PHN2005745
Bes-Rastrollo M, Pérez Valdivieso JR, Sánchez-Villegas A et al (2005) Validación del peso e índice de masa corporal auto-declarados de los participantes de una cohorte de graduados universitarios. Rev Esp Obes 3:352–358
Monteiro CA, Cannon G, Levy R et al (2016) Nova. The star shines bright [food classificiation. Public health]. World Nutr 7:28–38
Shivappa N, Sandin S, Lof M et al (2015) Prospective study of dietary inflammatory index and risk of breast cancer in Swedish women. Br J Cancer 113:1099–1103. https://doi.org/10.1038/bjc.2015.304
Frankenfield D, Roth-Yousey L, Compher C (2005) Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: a systematic review. J Am Diet Assoc 105:775–789. https://doi.org/10.1016/j.jada.2005.02.005
Li XJ, Ren ZJ, Qin JW et al (2013) Coffee consumption and risk of breast cancer: an up-to-date meta-analysis. PLoS ONE 8:e52681. https://doi.org/10.1371/journal.pone.0052681
Gierach GL, Freedman ND, Andaya A et al (2012) Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer 131:452–460. https://doi.org/10.1002/ijc.26372
Bhoo-Pathy N, Peeters PHM, Uiterwaal CSPM et al (2015) Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European prospective investigation into cancer and nutrition (EPIC) cohort study. Breast Cancer Res 17:15. https://doi.org/10.1186/s13058-015-0521-3
Fuller M, Rao NZ (2017) The effect of time, roasting temperature, and grind size on caffeine and chlorogenic acid concentrations in cold brew coffee. Sci Rep 7:17979. https://doi.org/10.1038/s41598-017-18247-4
Choi S, Jung S, Ko KS (2018) Effects of coffee extracts with different roasting degrees on antioxidant and anti-inflammatory systems in mice. Nutrients. https://doi.org/10.3390/nu10030363
Del Castillo MD, Ames JM, Gordon MH (2002) Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem 50:3698–3703. https://doi.org/10.1021/jf011702q
Clarke RJ, Vitzthum OG (2008) Coffee: recent developments. Blackwell Science, Malden
Alves RC, Almeida IMC, Casal S, Oliveira MBPP (2010) Isoflavones in coffee: influence of species, roast degree, and brewing method. J Agric Food Chem 58:3002–3007. https://doi.org/10.1021/jf9039205
Gloess AN, Schönbächler B, Klopprogge B et al (2013) Comparison of nine common coffee extraction methods: Instrumental and sensory analysis. Eur Food Res Technol 236:607. https://doi.org/10.1007/s00217-013-1917-x
Liang N, Kitts DD (2015) Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients 8(1):pii: E16. https://doi.org/10.3390/nu8010016
Sato Y, Itagaki S, Kurokawa T et al (2011) In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharm 403:136–138. https://doi.org/10.1016/j.ijpharm.2010.09.035
Tharaheswari M, Jayachandra Reddy N, Kumar R et al (2014) Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats. Mol Cell Biochem 396:161–174. https://doi.org/10.1007/s11010-014-2152-x
Lee KJ, Choi JH, Jeong HG (2007) Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 45:2118–2125. https://doi.org/10.1016/j.fct.2007.05.010
Park GH, Song HM, Jeong JB (2017) Kahweol from coffee induces apoptosis by upregulating activating transcription factor 3 in human colorectal cancer cells. Biomol Ther 25:337–343. https://doi.org/10.4062/biomolther.2016.114
Rosendahl AH, Perks CM, Zeng L et al (2015) Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer. Clin Cancer Res 21:1877–1887. https://doi.org/10.1158/1078-0432.CCR-14-1748
Lopez-Garcia E, Guallar-Castillon P, Leon-Muñoz L et al (2014) Coffee consumption and health-related quality of life. Clin Nutr 33:143–149. https://doi.org/10.1016/j.clnu.2013.04.004
Martinez-Gonzalez MA, Martin-Calvo N (2016) Mediterranean diet and life expectancy; beyond olive oil, fruits, and vegetables. Curr Opin Clin Nutr Metab Care 1:1–14. https://doi.org/10.1097/MCO.0000000000000316
Acknowledgements
We thank very specially all participants in the SUN cohort for their long-standing and enthusiastic collaboration and our advisors from Harvard TH Chan School of Public Health Walter Willett, Alberto Ascherio, Frank B. Hu and Meir J. Stampfer who helped us to design the SUN Project, the PREDIMED study and the PREDIMED-PLUS ongoing trial. ARN was supported by the Fundación Científica Asociación Española Contra el Cáncer (AECC) (Scientific Foundation of the Spanish Association Against Cancer). We thank other members of the SUN Group: Alonso A, Álvarez-Álvarez I, Balaguer A, Barbagallo M, Barrientos I, Barrio-López MT, Basterra-Gortari FJ, Battezzati A, Bazal P, Benito S, Bertoli S, Bes-Rastrollo M, Beulen Y, Beunza JJ, Buil-Cosiales P, Canales M, Carlos S, Carmona L, Cervantes S, Cristobo C, de Irala J, de la Fuente-Arrillaga C, de la O V, de la Rosa PA, Delgado-Rodríguez M, Díaz-Gutiérrez J, Díez Espino J, Domínguez L, Donat-Vargas C, Donazar M, Eguaras S, Fernández-Montero A, Fresán U, Galbete C, García-Arellano A, García López M, Gardeazábal I, GutiérrezBedmar M, Gomes-Domingos AL, Gómez-Donoso C, Gómez-Gracia E, Goñi E, Goñi L, Guillén F, Henríquez P, Hernández A, Hershey MS, Hidalgo-Santamaría M, Hu E, Lahortiga F, Leone A, Llorca J, López del Burgo C, Marí A, Marques I, Martí A, Martín Calvo N, Martín-Moreno JM, Martínez JA, Martínez-Lapiscina EH, Mendonça R, Menéndez C, Molendijk M, Molero P, Murphy K, Muñoz M, NúñezCórdoba JM, Pajares R, Papadaki A, Parletta N, Pérez de Ciriza P, Pérez Cornago A, Pérez de Rojas J, Pimenta AM, Pons J, Ramallal R, Razquin C, Rico-Campà A, Ruano C, Ruiz L, Ruiz-Canela M, Ruiz Zambrana A, Salgado E, San Julián B, Sánchez D, Sánchez-Bayona R, Sánchez-Tainta A, Sánchez-Villegas A, Santiago S, Sayón-Orea C, Schlatter J, Serrano-Martinez M, Toledo J, Tortosa A, Valencia F, Vázquez Z, Zarnowiecki D, Zazpe I.
Funding
The SUN Project has received funding from the Spanish Government-Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, and G03/140), the Navarra Regional Government (27/2011, 45/2011, 122/2014), and the University of Navarra.
Author information
Authors and Affiliations
Contributions
ET, and MAM-G designed research; ET, SC and MAM-G conducted research; CS-Q, AR-N, AMN and AG analyzed data; and CS-Q wrote the paper. MAM-G had primary responsibility for final content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sánchez-Quesada, C., Romanos-Nanclares, A., Navarro, A.M. et al. Coffee consumption and breast cancer risk in the SUN project. Eur J Nutr 59, 3461–3471 (2020). https://doi.org/10.1007/s00394-020-02180-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-020-02180-w